Literature DB >> 32227076

Life-threatening cardiac tamponade complicating myo-pericarditis in COVID-19.

Alina Hua1, Kevin O'Gallagher1, Daniel Sado1, Jonathan Byrne1.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32227076      PMCID: PMC7184427          DOI: 10.1093/eurheartj/ehaa253

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


× No keyword cloud information.
A 47-year-old presented with chest pain and breathlessness. She was positive for COVID-19. Echocardiogram showed cardiac tamponade, and pericardiocentesis was performed. This is the first reported case of COVID-19-associated cardiac tamponade. A 47-year-old Afro-Caribbean with previous myopericarditis was admitted in March 2020 with breathlessness, chest pain, dry cough, and subjective fevers. She had no cardiovascular risk factors. An angiogram in 2017 had shown unobstructed coronary arteries. On examination, she was afebrile (36.9°C), hypotensive (80/50 mmHg), and tachycardic (110 b.p.m.). A 12-lead ECG showed sinus tachycardia and concave infero-lateral ST elevation (Panel ). Chest X-ray showed mild pulmonary congestion (Panel ). Troponin T levels were 225 and 253 ng/L. Echocardiogram demonstrated normal left ventricular function and a global pericardial effusion with a maximum depth of 1.1 cm and no tamponade (Panel ). A nasopharyngeal swab specimen was sent for viral respiratory pathogens; all were negative except for COVID-19. Despite initial i.v. fluid resuscitation, she did not respond and was transferred to the intensive treatment unit (ITU) for vasopressor support. Repeat echocardiogram revealed further accumulation of pericardial effusion to a maximal depth of 2 cm, with evidence of cardiac tamponade (Panel ). Her haemodynamic parameters worsened, including hypotension and tachycardia. Pericardiocentesis was performed in view of acute deterioration. Due to her clinical condition and infective status, it was deemed unsuitable to transfer her to the cardiac laboratory for fluoroscopic-guided pericardiocentesis. This was therefore performed on the ITU under echocardiographic guidance. Improvement in haemodynamic parameters was observed immediately. A total of 540 mL of serosanguinous fluid was drained and tested negative for COVID-19. (Panel ) A 12-lead ECG shows concave ST elevation in infero-lateral leads. (Panel ) Chest X-ray shows mild pulmonary congestion and increased vascular markings in the right lower zone. (Panel ) Initial echocardiogram shows a small to moderate amount of pericardial effusion. (Panel ) Repeat echocardiogram shows further accumulation of pericardial fluid. This case report highlights the first cardiac tamponade case in COVID-19. Cardiac tamponade is an important differential to consider in a deteriorating patient with COVID-19. Conflict of interest: none declared.
  78 in total

1.  Acute pericarditis in a patient with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a case report and review of the literature on SARS-CoV-2 cardiological manifestations.

Authors:  Viral D Patel; Khushbu H Patel; Dhairya A Lakhani; Rupak Desai; Deep Mehta; Priyank Mody; Sumit Pruthi
Journal:  AME Case Rep       Date:  2021-01-25

2.  Acute cardiac injury in adult hospitalized COVID-19 patients in Zhuhai, China.

Authors:  Lizi Jin; Wenyi Tang; Lizheng Song; Liyun Luo; Zhijuan Zhou; Xiuwu Fan; Jinyou Zhang; Niujian Wu; Kan Liu; Jian Chen
Journal:  Cardiovasc Diagn Ther       Date:  2020-10

Review 3.  Cardio-oncology care in the era of the coronavirus disease 2019 (COVID-19) pandemic: An International Cardio-Oncology Society (ICOS) statement.

Authors:  Daniel Lenihan; Joseph Carver; Charles Porter; Jennifer E Liu; Susan Dent; Paaladinesh Thavendiranathan; Joshua D Mitchell; Anju Nohria; Michael G Fradley; Iskra Pusic; Keith Stockerl-Goldstein; Anne Blaes; Alexander R Lyon; Sarju Ganatra; Teresa López-Fernández; Rupal O'Quinn; Giorgio Minotti; Sebastian Szmit; Daniela Cardinale; Jose Alvarez-Cardona; Giuseppe Curigliano; Tomas G Neilan; Joerg Herrmann
Journal:  CA Cancer J Clin       Date:  2020-09-10       Impact factor: 508.702

4.  Classification of COVID-19 electrocardiograms by using hexaxial feature mapping and deep learning.

Authors:  Mehmet Akif Ozdemir; Gizem Dilara Ozdemir; Onan Guren
Journal:  BMC Med Inform Decis Mak       Date:  2021-05-25       Impact factor: 2.796

5.  Coronavirus disease 2019 (COVID-19)-associated constrictive pericarditis.

Authors:  Jennifer Kate Beckerman; Mohammad Alarfaj; Cynthia M Tracy; Ariel D Faiwiszewski; Andrew D Choi
Journal:  BMJ Case Rep       Date:  2021-05-11

Review 6.  Pericardial Diseases in COVID19: a Contemporary Review.

Authors:  Muhammad M Furqan; Beni R Verma; Paul C Cremer; Massimo Imazio; Allan L Klein
Journal:  Curr Cardiol Rep       Date:  2021-06-03       Impact factor: 2.931

Review 7.  Mechanisms of COVID-19-induced cardiovascular disease: Is sepsis or exosome the missing link?

Authors:  Mallikarjun Patil; Sarojini Singh; John Henderson; Prasanna Krishnamurthy
Journal:  J Cell Physiol       Date:  2020-10-20       Impact factor: 6.384

8.  COVID-19 and Cardiomyopathy: A Systematic Review.

Authors:  Fatemeh Omidi; Bahareh Hajikhani; Seyyedeh Neda Kazemi; Ardeshir Tajbakhsh; Sajedeh Riazi; Mehdi Mirsaeidi; Ali Ansari; Masoud Ghanbari Boroujeni; Farima Khalili; Sara Hadadi; Mohammad Javad Nasiri
Journal:  Front Cardiovasc Med       Date:  2021-06-17

9.  Subacute effusive-constrictive pericarditis in a patient with COVID-19.

Authors:  Rodica Diaconu; Lucian Popescu; Anda Voicu; Ionut Donoiu
Journal:  BMJ Case Rep       Date:  2021-06-11

10.  Pre-existing cardiovascular disease rather than cardiovascular risk factors drives mortality in COVID-19.

Authors:  Kevin O'Gallagher; Anthony Shek; Ajay M Shah; Rosita Zakeri; Daniel M Bean; Rebecca Bendayan; Alexandros Papachristidis; James T H Teo; Richard J B Dobson
Journal:  BMC Cardiovasc Disord       Date:  2021-07-03       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.